Cancer Therapeutics (CT) Program
The goal of the Cancer Therapeutics (CT) Program is to foster the development of novel therapeutic, chemopreventive and biomarker strategies that can be translated into more effective clinical applications through proof-of-principle, early-phase clinical and correlative science studies.
The thematic areas and specific aims of the CT Program are:
- Drug Development and Delivery: To foster the development and enhanced delivery of new therapeutic and preventive agents.
- Biomarkers: To promote discovery and utilization of biomarkers that can be used for diagnosis, prognosis and prediction of response.
- Developmental Therapeutics: To design and conduct innovative early-phase clinical trials integrated with correlative science studies.
- Lacey McNally, PhD Program Co-Leader
-
Kathleen Moore, MD
Program Co-Leader (Interim)
Explore Supportive Care services for your cancer journey
Learn More
Find out if you’re at risk for diabetes
Learn More
See what our commitment to ending diabetes in this century means for you
Learn More
-
Identification of Poison Ivy is Key in Preventing Exposures
An expert in disguise, poison ivy may often be mistaken for a weed growing along your back fence, near a pathway at your local park, or deep in the ...
Read More -
Oklahoma Children's Hospital OU Health Offers Free Meals for Children this Summer
As part of its commitment to leading health care and improving the lives of all children in the community, Oklahoma Children’s Hospital OU Health, in ...
Read More -
OU Health Sciences Center Enrolling Youth in National Study of ‘Long COVID’
OKLAHOMA CITY — The University of Oklahoma Health Sciences Center is part of a national study to better understand the long-term effects of COVID-19 ...
Read More